Skip to main content
Log in

Neutrophilenreiche und pustulöse Dermatitiden

Neue autoinflammatorische Erkrankungen und Syndrome

Neutrophilic and pustular dermatoses

New autoinflammatory diseases and syndromes

  • Schwerpunkt: Entzündliche Dermatosen
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Es werden nichtinfektiöse entzündliche Dermatosen mit überwiegend neutrophilen Infiltraten sowie pustulöse Dermatosen beschrieben, deren Infiltratdichte von spärlich (bei der Urtikaria) bis sehr dicht mit Leukozytoklasie (z. B. Sweet-Syndrom oder Pyoderma gangraenosum) variiert. Neutrophile Dermatosen werden durch diverse nichtinfektiöse Immunmechanismen ausgelöst. In den letzten Jahren wurden zudem vermehrt ursächliche Mutationen entdeckt (z. B. NLRC4-Mutation bei Cryopyrin-assoziierten periodischen Fiebersyndromen [CAPS] und anderen autoinflammatorischen Syndromen; IL36RN-Mutationen bei pustulöser Psoriasis) und entsprechende zielgerichtete Therapien entwickelt. Neutrophile Dermatosen sind von großer klinischer Bedeutung, da ihnen benigne oder maligne Erkrankungen zugrunde liegen können.

Abstract

This article reviews noninfectious inflammatory dermatoses with mainly neutrophilic infiltrates and the formation of pustules. The infiltrate containing neutrophils may either be mild as in urticaria or very dense, even with leukocytoclasia, as in Sweet syndrome or pyoderma gangrenosum. Neutrophilic infiltrates and pustular eruptions are caused by different noninfectious immunomechanisms. For some of them, mutations have been found (e.g. NLRC4 mutation in cryopyrin-associated periodic syndromes (CAPS) leading to activation of the inflammasome; IL36RN mutation in pustular psoriasis resulting in uncontrolled IL36 signaling). Neutrophilic dermatoses are of high interest, as they may be the cause of underlying benign or malignant conditions. In recent years, efficient targeted therapies have been developed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5
Abb. 6

Literatur

  1. Baartman B, Kosari P, Warren CC et al (2014) Sight-threatening ocular manifestations of acute febrile neutrophilic dermatosis (Sweet’s syndrome). Dermatology 228(3):193–197

    Article  PubMed  Google Scholar 

  2. Bidyasar S, Montoya M, Suleman K, Markowitz AB (2008) Sweet syndrome associated with granulocyte colony-stimulating factor. J Clin Oncol 26(26):4355–4356

    Article  PubMed  Google Scholar 

  3. Brehler R, Reimann S, Bonsmann G, Metze D (1997) Neutrophilic hidradenitis induced by chemotherapy involves eccrine and apocrine glands. Am J Dermatopathol 19(1):73–78

    Article  CAS  PubMed  Google Scholar 

  4. Broekaert SM, Böer-Auer A, Kerl K et al (2016) Neutrophilic epitheliotropism is a histopathological clue to neutrophilic urticarial dermatosis. Am J Dermatopathol 38(1):39–49

    Article  PubMed  Google Scholar 

  5. Christophers E, Metzler G, Röcken M (2014) Bimodal immune activation in psoriasis. Br J Dermatol 170(1):59–65

    Article  CAS  PubMed  Google Scholar 

  6. Cohen PR (2009) Neutrophilic dermatoses: a review of current treatment options. Am J Clin Dermatol 10(5):301–312

    Article  PubMed  Google Scholar 

  7. Cohen PR, Kurzrock R (2002) Sweet’s syndrome: a review of current treatment options. Am J Clin Dermatol 3(2):117–131

    Article  PubMed  Google Scholar 

  8. Dib EG, Ifthikharuddin JJ, Scott GA et al (2005) Neutrophilic eccrine hidradenitis induced by imatinib mesylate (Gleevec) therapy. Leuk Res 29(2):233–234

    Article  CAS  PubMed  Google Scholar 

  9. Giasuddin AS, El-Orfi AH, Ziu MM, El-Barnawi NY (1998) Sweet’s syndrome: Is the pathogenesis mediated by helper T cell type 1 cytokines? J Am Acad Dermatol 39(6):940–943

    Article  CAS  PubMed  Google Scholar 

  10. Harrist TJ, Fine JD, Berman RS et al (1982) Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 118(4):263–266

    Article  CAS  PubMed  Google Scholar 

  11. Herms F, Franck N, Kramkimel N et al (2017) Neutrophilic eccrine hidradenitis in two patients treated with BRAF inhibitors: a new cutaneous adverse event. Br J Dermatol 176(6):1645–1648

    Article  CAS  PubMed  Google Scholar 

  12. Imhof L, Meier B, Frei P et al (2015) Severe Sweet’s syndrome with elevated cutaneous interleukin-1β after azathioprine exposure: case report and review of the literature. Dermatology 230(4):293–298

    Article  CAS  PubMed  Google Scholar 

  13. Kastner DL, Aksentijevich I, Goldbach-Mansky R (2010) Autoinflammatory disease reloaded: a clinical perspective. Cell 140:784–790

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Kieffer C, Cribier B, Lipsker D (2009) Neutrophilic urticarial dermatosis: a variant of neutrophilic urticaria strongly associated with systemic disease. Report of 9 new cases and review of the literature. Medicine 88(1):23–31

    Article  PubMed  Google Scholar 

  15. Magro CM, Momtahen S, Nguyen GH, Wang X (2015) Histiocytoid Sweet’s syndrome: a localized cutaneous proliferation of macrophages frequently associated with chronic myeloproliferative disease. Eur J Dermatol 25(4):335–341

    Article  CAS  PubMed  Google Scholar 

  16. Marcoval J, Martín-Callizo C, Valentí-Medina F et al (2016) Sweet syndrome: long-term follow-up of 138 patients. Clin Exp Dermatol 41(7):741–746

    Article  CAS  PubMed  Google Scholar 

  17. Marini M, Wright D, Ropolo M (2002) Neutrophilic eccrine hidradenitis secondary to topotecan. J Dermatolog Treat 13(1):35–37

    Article  CAS  PubMed  Google Scholar 

  18. Marzano AV, Borghi A, Meroni PL, Cugno M (2016) Pyoderma gangrenosum and its syndromic forms: evidence for a link with autoinflammation. Br J Dermatol 175(5):882–891

    Article  CAS  PubMed  Google Scholar 

  19. Marzano AV, Cugno M, Trevisan V et al (2010) Role of inflammatory cells, cytokines and matrix metalloproteinases in neutrophil-mediated skin diseases. Clin Exp Immunol 162(1):100–107

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Marzano AV, Ishak RS, Saibeni S et al (2013) Autoinflammatory skin disorders in inflammatory bowel diseases, pyoderma gangrenosum and Sweet’s syndrome: a comprehensive review and disease classification criteria. Clin Rev Allergy Immunol 45(2):202–210

    Article  CAS  PubMed  Google Scholar 

  21. McDermott MF, Aksentijevich I, Galon J et al (1999) Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell 97(1):133–144

    Article  CAS  PubMed  Google Scholar 

  22. Naim M, Weyers W, Metze D (2011) Histopathologic features of exanthematous drug eruptions of the macular and papular type. Am J Dermatopathol 33(7):695–704

    Article  PubMed  Google Scholar 

  23. Navarini AA, Burden AD, Capon F et al (2017) ERASPEN Network. European consensus statement on phenotypes of pustular psoriasis. J Eur Acad Dermatol Venereol 31(11):1792–1799

    Article  CAS  PubMed  Google Scholar 

  24. Rochet NM, Chavan RN, Cappel MA et al (2013) Sweet syndrome: clinical presentation, associations, and response to treatment in 77 patients. J Am Acad Dermatol 69(4):557–564

    Article  CAS  PubMed  Google Scholar 

  25. Roujeau JC, Bioulac-Sage P, Bourseau C et al (1991) Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol 127(9):1333–1338

    Article  CAS  PubMed  Google Scholar 

  26. Satra K, Zalka A, Cohen PR, Grossman ME (1994) Sweet’s syndrome and pregnancy. J Am Acad Dermatol 30(2 Pt 2):297–300

    Article  CAS  PubMed  Google Scholar 

  27. Stahr BJ, Cooper PH, Caputo RV (1994) Idiopathic plantar hidradenitis: a neutrophilic eccrine hidradenitis occurring primarily in children. J Cutan Pathol 21(4):289–296

    Article  CAS  PubMed  Google Scholar 

  28. Strutton G, Weedon D, Robertson I (1995) Pustular vasculitis of the hands. J Am Acad Dermatol 32:192–198

    Article  CAS  PubMed  Google Scholar 

  29. Turan H, Kaya E, Gurlevik Z et al (2012) Neutrophilic eccrine hidradenitis induced by cetuximab. Cutan Ocul Toxicol 31(2):148–150

    Article  CAS  PubMed  Google Scholar 

  30. Broekaert SMC, Metze D (2016) Dermal entzündliche Dermatosen. In: Cerroni L, Garbe C, Metze D, Kutzner H, Kerl H (Hrsg) Histopathologie der Haut. Springer Reference Medizin. Springer, Berlin, Heidelberg, S 171–183

    Chapter  Google Scholar 

  31. Möckel SMC, Metze D (2020) Neutrophilic and pustular eruptions. In: Hoang M, Selim M (Hrsg) Hospital-based dermatopathology. Springer, Cham, S 93–136

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sigrid M. C. Möckel.

Ethics declarations

Interessenkonflikt

S. M. C. Möckel und D. Metze geben an, dass kein Interessenkonflikt besteht.

Für diesen Beitrag wurden von den Autoren keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.

Additional information

Schwerpunktherausgeber

T. Mentzel, Friedrichshafen

E. Bierhoff, Bonn

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Möckel, S.M.C., Metze, D. Neutrophilenreiche und pustulöse Dermatitiden. Pathologe 41, 364–370 (2020). https://doi.org/10.1007/s00292-020-00784-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-020-00784-x

Schlüsselwörter

Keywords

Navigation